137 related articles for article (PubMed ID: 7817479)
1. Resolution time of Escherichia coli cystitis is correlated with levels of preinfection antibody to the infecting Escherichia coli strain.
Hopkins WJ; Uehling DT
Urology; 1995 Jan; 45(1):42-6. PubMed ID: 7817479
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic antibody responses accompany spontaneous resolution of experimental cystitis in cynomolgus monkeys.
Hopkins WJ; Uehling DT; Balish E
Infect Immun; 1987 Sep; 55(9):1951-6. PubMed ID: 3305357
[TBL] [Abstract][Full Text] [Related]
3. Vaginal immunization against induced cystitis in monkeys.
Uehling DT; Hopkins WJ; Jensen J; Balish E
J Urol; 1987 Feb; 137(2):327-9. PubMed ID: 3543412
[TBL] [Abstract][Full Text] [Related]
4. Serum and urogenital antibody responses to Escherichia coli pili in cystitis.
Rene P; Dinolfo M; Silverblatt FJ
Infect Immun; 1982 Nov; 38(2):542-7. PubMed ID: 6128309
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses in urine and serum against Escherichia coli O antigen in childhood urinary tract infection.
Akerlund AS; Ahlstedt S; Hanson LA; Jodal U
Acta Pathol Microbiol Scand C; 1979 Feb; 87C(1):29-36. PubMed ID: 373383
[No Abstract] [Full Text] [Related]
6. UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens.
Sarkissian CA; Alteri CJ; Mobley HLT
Vaccine; 2019 Aug; 37(35):4937-4946. PubMed ID: 31320216
[TBL] [Abstract][Full Text] [Related]
7. Serum and urinary immunoglobulin in the rat model of acute urinary tract infection.
Herrera HJ; Davis CP; Cohen MS; Anderson MD; Warren MM
Life Sci; 1991; 48(21):2047-56. PubMed ID: 2034034
[TBL] [Abstract][Full Text] [Related]
8. Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.
Hanson LA; Ahlstedt S; Fasth A; Jodal U; Kaijser B; Larsson P; Lindberg U; Olling S; Sohl-Akerlund A; Svanborg-Edén C
J Infect Dis; 1977 Aug; 136 Suppl():S144-9. PubMed ID: 330773
[TBL] [Abstract][Full Text] [Related]
9. Antibodies in Escherichia coli urinary tract infection.
Fries D; Delavelle F; Mathieu D; Jacques L; Renault L
Proc Eur Dial Transplant Assoc; 1977; 14():535-40. PubMed ID: 341144
[TBL] [Abstract][Full Text] [Related]
10. Comparison of O antigen-specific urinary immunoglobulins to Escherichia coli in normal women and women prone to Escherichia coli cystitis.
Short KL; West CA; Brinson D; Polk HC; Cost KM; Brown GL; O'Connor C
Br J Urol; 1987 Jul; 60(1):47-50. PubMed ID: 2441789
[TBL] [Abstract][Full Text] [Related]
11. Vaginal immunization of monkeys against urinary tract infection with a multi-strain vaccine.
Uehling DT; Hopkins WJ; James LJ; Balish E
J Urol; 1994 Jan; 151(1):214-6. PubMed ID: 8254817
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli.
Langermann S; Möllby R; Burlein JE; Palaszynski SR; Auguste CG; DeFusco A; Strouse R; Schenerman MA; Hultgren SJ; Pinkner JS; Winberg J; Guldevall L; Söderhäll M; Ishikawa K; Normark S; Koenig S
J Infect Dis; 2000 Feb; 181(2):774-8. PubMed ID: 10669375
[TBL] [Abstract][Full Text] [Related]
13. The host-parasite relationship in urinary tract infections.
Hanson LA; Ahlstedt S; Jodal U; Kaijser B; Larsson P; Lidin-Janson G; Lincoln K; Lindberg U; Mattsby I; Olling S; Peterson H; Sohl A
Kidney Int Suppl; 1975 Aug; 4():S28-34. PubMed ID: 1104979
[No Abstract] [Full Text] [Related]
14. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
[TBL] [Abstract][Full Text] [Related]
15. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
16. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination.
Langermann S; Palaszynski S; Barnhart M; Auguste G; Pinkner JS; Burlein J; Barren P; Koenig S; Leath S; Jones CH; Hultgren SJ
Science; 1997 Apr; 276(5312):607-11. PubMed ID: 9110982
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to outer membrane proteins of Escherichia coli in healthy persons and patients with bacteremia.
Henriksen AZ; Maeland JA
J Clin Microbiol; 1987 Nov; 25(11):2181-8. PubMed ID: 3320085
[TBL] [Abstract][Full Text] [Related]
19. Total and specific immunoglobulin response to acute and chronic urinary tract infections in a rat model.
Davis CP; Cohen MS; Anderson MD; Reinarz JA; Warren MM
J Urol; 1987 Nov; 138(5):1308-17. PubMed ID: 3312646
[TBL] [Abstract][Full Text] [Related]
20. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
